Evidence map›Paper›PMID 39169200›Full record

ArticleEMBO reports2024

Novel mechanisms of MITF regulation identified in a mouse suppressor screen.

Hong Nhung Vu, Matti Már Valdimarsson, Sara Sigurbjörnsdóttir, Kristín Bergsteinsdóttir, Julien Debbache, Keren Bismuth, Deborah A Swing, Jón H Hallsson, Lionel Larue, Heinz Arnheiter and 4 more

Abstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Hong Nhung VuDepartment of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102, Reykjavík, Iceland.ORCID 0000-0002-8262-900X
Matti Már ValdimarssonDepartment of Biochemistry, Science Institute, School of Engineering and Natural Sciences, University of Iceland, Sturlugata 7, 102, Reykjavík, Iceland.
Sara SigurbjörnsdóttirDepartment of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102, Reykjavík, Iceland.ORCID 0000-0002-3030-8888
Kristín BergsteinsdóttirDepartment of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102, Reykjavík, Iceland.
Julien DebbacheMammalian Development Section, NINDS, NIH, Bethesda, MD, 20892-3706, USA.
Keren BismuthMammalian Development Section, NINDS, NIH, Bethesda, MD, 20892-3706, USA.
Deborah A SwingMouse Cancer Genetics Program, NCI, Frederick, MD, 21702-1201, USA.
Jón H HallssonDepartment of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102, Reykjavík, Iceland.ORCID 0000-0002-9127-2137
Lionel LarueInstitut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, 91405, Orsay, France.ORCID 0000-0002-2010-6107
Heinz ArnheiterMammalian Development Section, NINDS, NIH, Bethesda, MD, 20892-3706, USA.ORCID 0000-0003-2537-1134
Neal G CopelandMouse Cancer Genetics Program, NCI, Frederick, MD, 21702-1201, USA.
Nancy A JenkinsMouse Cancer Genetics Program, NCI, Frederick, MD, 21702-1201, USA.
Petur O HeidarssonDepartment of Biochemistry, Science Institute, School of Engineering and Natural Sciences, University of Iceland, Sturlugata 7, 102, Reykjavík, Iceland.ORCID 0000-0003-2027-5434
Eiríkur SteingrímssonDepartment of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Sturlugata 8, 102, Reykjavík, Iceland. eirikurs@hi.is.ORCID 0000-0001-5826-7486

Funding

Icelandic Research Fund 217768
6 · The paper itself

Abstract

MITF, a basic Helix-Loop-Helix Zipper (bHLHZip) transcription factor, plays vital roles in melanocyte development and functions as an oncogene. We perform a genetic screen for suppressors of the Mitf-associated pigmentation phenotype in mice and identify an intragenic Mitf mutation that terminates MITF at the K316 SUMOylation site, leading to loss of the C-end intrinsically disordered region (IDR). The resulting protein is more nuclear but less stable than wild-type MITF and retains DNA-binding ability. As a dimer, it can translocate wild-type and mutant MITF partners into the nucleus, improving its own stability thus ensuring nuclear MITF supply. smFRET analysis shows interactions between K316 SUMOylation and S409 phosphorylation sites across monomers; these interactions largely explain the observed effects. The recurrent melanoma-associated E318K mutation in MITF, which affects K316 SUMOylation, also alters protein regulation in concert with S409. This suggests that residues K316 and S409 of MITF are impacted by SUMOylation and phosphorylation, respectively, mediating effects on nuclear localization and stability through conformational changes. Our work provides a novel mechanism of genetic suppression, and an example of how apparently deleterious mutations lead to normal phenotypes.

Indexed as

Microphthalmia-Associated Transcription FactorSumoylationAnimalsCell NucleusHumansMiceMutationPhenotypePhosphorylationProtein StabilityMicrophthalmia-Associated Transcription FactorMITF protein, humanMitf protein, mouseMitfNuclear ExportProtein StabilitySuppressorTranscription

Identifiers

PMID39169200
PMCPMC11467436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.